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Abstract
Background: Identifying and treating problem alcohol use among people who also use illicit drugs is a challenge.
Primary care is well placed to address this challenge but there are several barriers which may prevent this occurring.
The objective of this study was to determine if a complex intervention designed to support screening and brief
intervention for problem alcohol use among people receiving opioid agonist treatment is feasible and acceptable to
healthcare providers and their patients in a primary care setting.
Methods: A randomised, controlled, pre-and-post design measured feasibility and acceptability of alcohol screening
based on recruitment and retention rates among patients and practices. Efficacy was measured by screening and brief
intervention rates and the proportion of patients with problem alcohol use.
Results: Of 149 practices that were invited, 19 (12.8 %) agreed to participate. At follow up, 13 (81.3 %) practices with 81
(62.8 %) patients were retained. Alcohol screening rates in the intervention group were higher at follow up than in the
control group (53 % versus 26 %) as were brief intervention rates (47 % versus 19 %). Four (18 %) people reduced their
problem drinking (measured by AUDIT-C), compared to two (7 %) in the control group.
Conclusions: Alcohol screening among people receiving opioid agonist treatment in primary care seems feasible. A
definitive trial is needed. Such a trial would require over sampling and greater support for participating practices to
allow for challenges in recruitment of patients and practices.
Keywords: Alcohol, Primary care, Screening, Agonist treatment, Methadone, General practice, Implementation,
Feasibility, Brief intervention, SBIRT
Background
Problem alcohol use, defined as a positive AUDIT (Alco-
hol Use Disorders Identification Test) score [1], is com-
mon among patients attending primary care for opioid
agonist treatment. Ryder et al. (2009) estimated that 35 %
of patients attending primary care for addiction treatment
had problem alcohol use [2], and higher rates have been
reported in more specialist addiction treatment centres
[3]. Among people receiving addiction treatment, problem
alcohol use poses additional challenges as alcohol is asso-
ciated with increased risk of mortality in this vulnerable
population [4]. It impacts adversely on many health issues
that commonly affect this population, e.g. chronic hepa-
titis C infection [5], increased risk of fatal opiate overdose
[6] and compromised metabolism of methadone [7]. To
address these challenges, psychosocial interventions in-
corporating alcohol screening and brief intervention (SBI)
can effectively identify patients with this problem and
guide management [8].
Screening, brief intervention, and referral to treatment
(SBIRT) for a range of substance use problems is a cost-
effective, comprehensive, and integrated system of early
intervention and treatment services for individuals who
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use tobacco, alcohol, or other drugs [9]. A review of
brief, multi-contact behavioural counselling interven-
tions among adult patients attending primary care found
such interventions reduced the average number of
drinks per week by 13–34 %, increased the proportion
drinking at moderate or low risk levels by 10–19 %, con-
cluding such interventions were feasible and potentially
highly effective components of an overall public health
approach to reducing problem alcohol use [10]. The
World Health Organisation (WHO) recommends that
health professionals provide alcohol SBI for heavy
drinkers, however, it is underused with less than 10 % of
those who might benefit from SBI, receiving a brief
intervention [11].
The integration of complex interventions which can in-
crease the uptake of screening and brief intervention in
primary care is a priority to address problem alcohol use
among patients attending primary care for opioid agonist
treatment. Primary care is an accessible and frequently
used health care service. It offers continued patient
centred care and an ideal setting for individual, group and
community interventions to encourage health promotion
and disease prevention. However, the ability to incorpor-
ate such interventions into practice may be challenged
through workload, lack of time, knowledge or skills [12].
This is especially the case for problem alcohol use among
people receiving opioid agonist treatment. Though com-
mon in this population [2], implementation rates of SBIRT
are low [13, 14], despite there being increased risks from
poly-drug use through additive or synergistic effects [15].
Interventions which promote screening and brief inter-
vention in practice are likely to benefit problem alcohol
use among this population [13, 16]. A cross sectional
study showed screening and brief intervention were in-
consistent and associated with practitioner and system
factors (such as lack of time, lack of specialist staff and
poor service availability), whereas experience / education
and integration with other services were among the key
enablers [17]. An educational intervention was subse-
quently developed to enable GPs to deliver brief interven-
tions for problem alcohol use among people receiving
opioid agonist treatment and its possible feasibility, ac-
ceptability and usefulness in practice was demonstrated in
a pilot study [18]. The PINTA (Psychosocial INTerven-
tions for problem Alcohol use) project has therefore fur-
ther developed a complex intervention (which includes
this educational intervention) to enhance screening and
brief intervention.
We aimed to determine if a complex intervention de-
signed to support screening and brief intervention for
problem alcohol use among people receiving opioid agon-
ist treatment is feasible and acceptable to healthcare pro-
viders and their patients in a primary care setting. The
specific objectives were: (i) to develop a multi-sided
complex intervention (incorporating practice visits, distri-
bution of best practice guidelines and education), (ii) to
explore its feasibility and acceptability, and (iii) to inform
the subsequent design of a definitive cluster randomised
trial by estimating the possible impact of the intervention
on practice (i.e. screening, brief intervention and referral
to treatment) and outcomes (i.e. the proportion of patients
with problem alcohol use).
Methods
We used a controlled pre-and-post intervention design
to establish the feasibility of a complex intervention to
promote SBI for problem alcohol use among people re-
ceiving opioid agonist treatment, with cluster random-
isation at the level of general practice [14]. Participants
(GPs, patients) were surveyed on addiction care pro-
cesses before and after the intervention (3 months).
The intervention consisted of two key components: (i)
an academic group intervening at practices (recruitment,
education, study procedures); and (ii) participating GPs
treating patients (screening, advice, study procedures).
Participants
Based on the recommendations for good practice in
pilot studies [19, 20], it was estimated that 160 patients
(attending 16 general practices) would be adequate to
examine the actual recruitment and retention rates (i.e.
feasibility), and to provide data on acceptability of study
processes and outcome measures, which would inform a
future definitive trial [21].
General practitioners (n = 16) were selected using ran-
dom stratified sampling, with geographical location
(Health Service Executive Mid-West and Dublin Mid-
Leinster regions) and the level of methadone provision
training forming the strata in the sampling [14]. To pre-
scribe methadone, GPs are subject to clinical audit and
must complete special training, while GPs providing
methadone treatment for 15 or more patients are subject
to more regular audit and advanced training. GPs who
prescribe methadone for less than 15 patients are re-
ferred to as “level 1 GPs”, and those prescribing for 15
or more as “level 2 GPs” [21].
Individual participants were recruited by GPs over a
16 week period between December 2013 and April 2014.
Participating practices were asked to recruit 10 consecutive
patients who were aged 18 years or over and receiving ad-
diction treatment / care (e.g. methadone) at the practice.
Patients were excluded from the study if they had language
difficulties (i.e., unable to speak, read, and write English suf-
ficiently well to complete study questionnaires), were
acutely intoxicated, and/or were cognitively impaired (in-
cluding severe mental health illness) to the extent that they
were unable to provide informed consent to participate.
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Participating practices were found to have an average time-
frame of five weeks to complete recruitment.
The study procedures [21] and sampling framework
[14] have been reported previously and recruitment
process / subsequent engagement with practices are out-
lined in Table 1.
Intervention
The complex intervention development was informed by
the U.K. Medical Research Council (MRC) ‘Framework
for design and evaluation of complex interventions to im-
prove health’ [18]. The complex intervention designed to
support screening and brief intervention for problem alco-
hol use among opioid agonist patients used in the study
consisted of: practice visits, distribution of best practice
guidelines, brief intervention training (see Table 2).
A staggered intervention design was adopted, whereby
participating practices were randomised to receive the
complex intervention after baseline data collection. The
control group received the complex intervention three
months later.
Data collection
Demographic details (GPs and patients) and data on
process / outcome measures (i.e. feasibility, acceptability
and possible efficacy), were measured at baseline and fol-
low up (three months) by completing study instruments
with GPs and patients, and by reviewing clinical records.
Health care professionals at participating practices also
completed a postal questionnaire on practice/professional
details, experience of training and attitudes.
Measures of feasibility
We measured the feasibility as numbers of recruited and
retained GPs and people receiving opioid agonist treat-
ment in primary care.
Measures of acceptability
GPs' attitudes towards the provision of care for patients
with alcohol use disorders were assessed pre / post inter-
vention. They completed the ‘Short Alcohol and Alcohol
Problems Perception Questionnaire’ (SAAPPQ). This 10-
item, 7-point Likert-type questionnaire measured the atti-
tudes of professionals towards the provision of care for pa-
tients with alcohol use disorders. Total scores range from
10 to 70, with lower scores indicative of more negative atti-
tudes. The role security domain within the SAAPPQ in-
cludes 2 sub-domains: role adequacy, and role legitimacy
(e.g. “I feel I can appropriately advise my patients about
drinking and its effects”; “I feel I have the right to ask pa-
tients questions about their drinking when necessary”).
Therapeutic commitment involves motivation, task specific
self-esteem, and work satisfaction [22]. Within the scales of
role security and therapeutic commitment (ratings on a 7-
point Likert scale ranging from ‘strongly agree’ to ‘strongly
disagree’) means were calculated. See Additional file 1 for
SAAPPQ scoring key.
GPs rated the importance of each of five barriers to al-
cohol screening, specifically: lack of training and educa-
tion, lack of time, lack of specialist staff, poor service
Table 1 Outline of researcher interaction with recruited
practices
• Initial invite / practice recruitment:
o 149 GPs received written invitation to participate.
o Invitation outlined: (a) study purpose; (b) remuneration for
administrative workload generated; (e) GP / practice requirements
on participation and content of the intervention.
o Sixteen practices were selected to participate in the study
• Practice Visits: Patient recruitment and baseline data collection was
completed over a series of four practice visits.
o Visit 1: Researcher visited practices to outline the study, explain
patient recruitment, and provided a resource pack outlining study
requirements in greater detail.
o Visit 2: Researcher facilitated practices to complete a register of
patients attending the practice for management of problem drug
use.
o Visit 3: Researcher conducted a detailed review of clinical records of
participating patients during the baseline data collection phase. GPs
were also asked about each patient’s problem alcohol use and
drug use by the researcher.
o Visit 4: Baseline patient interviews conducted in person or by
telephone.
• Three months after the complex intervention had been delivered (see
summary box 2), follow-up data was collected (i.e. patient interviews,
review of clinical records and GP questionnaires)
• The ‘control group’ received the complex intervention upon
completion of follow-up data collection.
Table 2 PINTA complex intervention description
• A multi-sided complex intervention strategy, incorporating practice
visits, distribution of best practice guidelines and education (including
CME-approved small group sessions); multimedia educational tools (i.e.
DVD); MI (motivational interviewing) related training presentation; and
demonstration of intervention implementation to attendees.
• Dissemination of a resource pack which included:
(i) Clinical guidelines for the management of problem alcohol use
among problem drug users;
(ii) ‘A Quick Question’ HSE (Health Service Executive) leaflet promoting
reduced alcohol use;
(iii) A multimedia educational video demonstrating screening using
AUDIT (Alcohol Use Disorders Identification Test) and delivering a
BI (brief intervention) using the ‘FRAMES’ model which identifies
key elements of brief intervention: feedback, responsibility, advice,
menu of strategies, empathy, and self-efficacy;
(iv) Resource manual with up-to-date information on support services
to help practices in the management of patients with problem
alcohol.
• Educational support for participating GPs following workshop. The
specific objectives were to: (i) outline the importance of routine, annual
screening of all problem drug users; (ii) encourage use of the full AUDIT
questionnaire for patients with positive annual screen; (iii) promote
delivery of brief intervention to patients in the ‘hazardous’ / ‘harmful’
category, and referral to specialist services for patients in the
‘dependent’ category.
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availability and attitude of patients. They rated their an-
swers on a Likert scale from one to five (1 =most im-
portant and 5 = least important; composite score 5–25).
Usefulness of training, practice visits, materials, guide-
lines and remuneration was also measured on a five-
point Likert scale (1 = very useful and 5 = not at all
useful; composite score 5–25).
In addition, qualitative interviews were conducted with
both patients and GPs to determine the acceptability of the
complex intervention. Semi-structured interviews were
conducted with 14 patients and eight General Practitioners
(GPs) who had been purposively sampled from practices
that had participated in the feasibility study. The interviews
were transcribed verbatim and analysed thematically. The
qualitative work is reported in more detail separately [23].
Process / outcome measures
Though not powered to determine effectiveness, the
possible impact of the intervention on care process was
measured by examining whether patients had received
alcohol screening, brief intervention and referral to a
specialist alcohol service in the previous three months
(i.e. the study duration). Possible impact of the interven-
tion on care outcomes was measured using the ‘AUDIT-
Consumption (AUDIT-C)’, a validated and practical
three-item screening test for alcohol use disorders or
risky drinking which consists of the first three questions
of the AUDIT pertaining to consumption [24]. The se-
lection threshold for positive AUDIT-C scores was ≥ 3
for women and ≥ 4 for men [25, 26].
Human subjects protection
The Irish College of General Practitioners’ (ICGP)
Research Ethics Committee approved the study. During
recruitment, GPs informed potential participants of
study objectives and procedures, provided written infor-
mation and asked them to provide their written in-
formed consent to participate. The study was conducted
in accordance with relevant ethical standards, the
Helsinki Declaration of 1975, as revised in 2000.
Data analysis
Per-protocol analysis was performed with respect to care
process and outcome measures. Means, frequencies and
percentages were calculated using Statistical Packages
for the Social Sciences (SPSS) version 21.0. To account
for potential cluster effects in a future definitive trial, an
intracluster correlation coefficient (ICC) for care process
and outcome measures was calculated [27].
Results
Characteristics of participants
Of 16 practices randomly sampled and allocated to ei-
ther intervention or control groups, 15 facilitated patient
recruitment and baseline data collection on 106 patients
(Fig. 1). At follow up, 13 practices (Table 3) facilitated
data collection on 81 patients (Table 4).
Overall, the study population (n = 81) was similar to
those receiving methadone in the national study reporting
prevalence of problem alcohol use in Ireland [2]. With the
exception of methadone dose (higher in intervention
group), both intervention (n = 34) and control (n = 47)
groups were comparable in terms of socio-demographic
characteristics and addiction characteristics (Table 4).
Feasibility
Of 149 invited, 19 GPs expressed an interest and were eli-
gible to participate. Of these 19 practices, we selected 16 by
stratified random sampling and 15 of those GPs completed
patient recruitment. One hundred and twenty nine patients
were recruited, from which we obtained baseline data by
reviewing charts (n = 129) and interviewing most of the pa-
tients (n = 106). At follow up, we collected data from 13
GPs. We also collected data by reviewing charts (n = 115)
and by interviewing 81 of those patients (see Fig. 1).
Acceptability
Of the seven GPs assigned to the intervention arm, six
completed the training and four took part in the educa-
tional outreach / practice visits.
The SAAPPQ score increased among both groups be-
tween baseline and follow up, but more so in the interven-
tion group (Table 5, +3.3 versus +1.6). Five out of the six
GPs in the intervention group revealed an improvement
in attitudes towards the provision of care for patients with
alcohol use disorders in comparison to four out of the
seven GPs in the control group. For the intervention
group attitudes regarding role security and therapeutic
commitment increased by 2.9 and 9.7 % respectively,
whereas there was an increase in scores relating to atti-
tudes on role security and therapeutic commitment of 4.6
and 1.75 % respectively for the control group.
The composite score for perceived barriers to imple-
menting SBI in general practice decreased for both groups
from baseline to follow up with a greater decrease in the
intervention group (–1.4 versus –0.6), with ‘lack of spe-
cialist support staff ’ the barrier which was most affected
(–1.0 versus –0.1).
When asked about which elements of the intervention
they found useful, four (66.7 %) indicated they found
hand-outs, guidelines, and remuneration ‘useful’ or ‘very
useful’. These were followed by training (3, 50.0 %) and
practice visits (2, 33.4 %). Overall, the mean composite
score for all five intervention elements at participating
practices was 10 (SD = 3.4, where 5 = very useful and 25 =
not at all useful).
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Process / outcome measures
With respect to process measures, the proportion of pa-
tients who had (in the past three months) been screened
for problem alcohol use was higher (53 % versus 26 %) in
the intervention compared to control group (Table 6).
This was also the case for the proportions who had re-
ceived a brief alcohol intervention (47 % versus 19 %) and
the proportion that had been referred for specialist alcohol
treatment (3 % versus 0 %). In the intervention group, 22
people had an abnormal AUDIT-C at baseline, while 18
had an abnormal AUDIT-C at follow up (18 % reduction).
In the control group, the number also fell from baseline to
follow up (29 to 27, 7 % reduction). In the intervention
group, while 14 people had an abnormal AUDIT at base-
line, this fell to 8 at follow up (43 % reduction). In the con-
trol group, the number also fell from baseline to follow up
(18 to 10, 44 % reduction). The intracluster correlation co-
efficient (ICC) and standard error for the proportion of
patients with positive AUDIT-C results were 0.11 (SE =
0.013). The ICC will be used to determine sample size for
the future definitive trial.
Discussion
The study aimed to examine the feasibility and accept-
ability a complex intervention to enhance identification
and treatment of problem alcohol use among people re-
ceiving opioid agonist treatment in primary care.
Though not adequately powered to examine effective-
ness the follow-up alcohol screening rates in the inter-
vention group were higher than in the control group
(53 % versus 26 %), as were alcohol brief intervention
rates (47 % versus 19 %). The follow-up prevalence of
problem alcohol use in the intervention group (mea-
sured by AUDIT-C) dropped by 18 %, compared to
seven per cent in the control group.
GP Recruitment
149 GPs invited
19 GPs accepted
16 GPs selected using stratified random sampling
Baseline Phase (16 GP participants)
1 Dropped out
15 GP Participants Retained for Baseline Data Collection Phase
129 Patient Participants Consented (129 Chart Reviews & 106 Patient 
Interviews)
Random Allocation 
15 GPs 
Intervention (n=8) and Control (n=7)
Dropouts: 2 Intervention GP practices and 11 patients from these practices
Follow Up Data Collection Phase
13 GP Participants
95 Patient Participants
14 Patient Drop Outs (Intervention (n=7) and Control (n=7))
Control
Post Baseline Data Collection
GPs (n= 7) Patients (n=47)
Intervention
Post Baseline Data Collection
GPs (n= 6) Patients (n=34)
Fig. 1 Flow Diagram showing the recruitment of participants from 16 General Practices
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The key parameters identified from this study for a de-
finitive cluster randomised controlled trial (RCT) to deter-
mine the effectiveness of this intervention were GP
recruitment rate (13 %), patient recruitment rate (81 %),
GP retention rate (81 %) and patient retention (63 %).
The GP recruitment rate was lower than planned. Re-
cruitment issues are echoed in other primary care re-
search [28, 29]. Recruitment in primary care has particular
challenges related to the characteristics of primary care
practitioners, their patients and the dispersed nature of
clinics [30]. Additional challenges, such as physical, psy-
chological co-morbidity and adverse social circumstances
[31] in conjunction with practices located in deprived
areas, should be considered when planning RCTs involv-
ing this group of patients.
Our GP recruitment strategy targeting socio-
economically deprived areas in the Dublin Mid-Leinster
and the Mid-West regions and use of postal invitations,
limited our recruitment rate and undermined the
generalizability of our findings. Although, there has been
significant growth in prevalence of opiate users outside
of Dublin [32], the lower number of patients receiving
opioid agonist treatment in the Mid-West region re-
sulted in a disproportionately lower acceptance rate than
the Dublin-Mid Leinster region. Future strategies will
encompass a larger sample size targeting a greater pro-
portion of MMT (methadone maintenance treatment)
GPs in Ireland and the implementation of a more rigor-
ous recruitment process. We will (i) Engage with net-
works of practices (thematic or geographical) with an
interest in conducting research and development in
MESUDs (Mental Health Substance Use Disorders) as a
key priority; (ii) Develop a relationship with practice staff
and ensure adequate practice support to enhance re-
cruitment and retention of practitioners and patients;
and (iii) Implement active recruitment measures, involv-
ing personal contact between researchers and practi-
tioners that avoids mailing unsolicited information,
which may also encourage participation.
Following a review of qualitative interviews with GPs,
time constraints were identified as the primary obstacle
in the implementation of the intervention. In addition,
some GPs tended to overestimate their competency in
detecting problem alcohol use relying on visual and ver-
bal cues from patients rather than screening patients
routinely. This highlights the need for greater researcher
support for GPs, improved study format and delivery of
educational intervention to improve SBI rates among
this cohort of patients.
Positive attitudes towards caring for patients with prob-
lem alcohol use were observed among participating GPs,
with the SAAPPQ score improving in both intervention
and control groups at follow up, and to a greater extent in
the intervention group, particularly in relation to thera-
peutic commitment. Though the improved SAAPPQ score
was modest, this is nonetheless important as attitudes are
important predictors of GPs’ involvement in managing al-
cohol problems (especially in role security and therapeutic
commitment domains) [33]. The CME-approved educa-
tional workshops to enable GPs to screen for or treat prob-
lem alcohol use among people receiving opioid agonist
treatment were also received favourably. Most useful
components of the training were hand-outs, guidelines and
remuneration. The findings suggest GPs found the inter-
vention useful. This is consistent with other research that
indicates training GPs in the management of alcohol use
disorders among people receiving opioid agonist treatment
is likely to be of use to GPs [18] and perhaps patients.
The assessment of perceived barriers to alcohol screening
suggested that training heightened GPs’ awareness of how
to manage problem alcohol use and focused their attention
on how to address the practicalities of implementing it in
their everyday consultations. The need for specialist staff
was the most important barrier further highlighting the
importance of implementing the provision of additional
support and resources for a less motivated cohort of GPs.
Table 3 Participating practices characteristics
Characteristic/Category GPs Total (N = 13)
Intervention (n = 6) Control (n = 7)
Geographical area of GP:
Ireland East 5 6
Ireland Mid-West 1 1
Level of training in providing addiction related care:
Level 1 GPa 2 3
Level 2 GPb 4 4
Gender of GP:
Male 5 7
Female 1 0
Type of Practice:
Mixedc 6 6
GMSd 0 1
Number of full time GPs per practice:
≤2 6 5
≥ 3 0 2
Practice Nurse:
Yes 5 6
No 1 1
aLevel 1GP: GPs who prescribe methadone for less than 15 patients are
referred to as “level 1 GPs”
bLevel 2 GP: GPs who prescribe methadone for 15 or more are referred to as
“level 2 GPs”
cMixed: Mixed Practice accepts both GMS patients and private patients
dGMS: General Medical Services Scheme provides free general practitioner
services and free drugs and medicines to persons with full eligibility
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Qualitative interviews found that while all GPs found
the intervention informative and feasible, most considered
it challenging to incorporate into practice. Barriers in-
cluded time constraints, and overlooking and underesti-
mating problem alcohol use among this cohort of
patients. Patients reported that (in the absence of the
intervention) their use of alcohol was rarely discussed with
their GP, and were reticent to initiate conversations on
their alcohol use for fear of having their methadone dose
reduced. The findings suggested that while a complex
intervention seems feasible and acceptable, the barriers
highlighted must be overcome to enable consistent, regu-
lar, and accurate screening by GPs.
Although screening for problem alcohol use is a pre-
vention priority in primary care for adults (especially
high risk groups such as people receiving opioid agonist
treatment [21]), thus far it has one of the lowest delivery
rates, with screening or intervention typically completed
only when a risk factor is evident [34]. Our study sug-
gests that if adequately supported, primary care pro-
viders can screen and intervene more, based on our
biased, small sample size. Furthermore education of GPs
on the importance of screening this cohort of patients
and the integration of the screening instrument within
electronic medical records can improve treatment for at
risk groups [35, 36].
Table 4 Characteristics of patient study population attending intervention and control practices at baseline
Characteristic/Category Intervention (n = 34) Control (n = 47)
n (%) Mean (SD) n (%) Mean (SD)
Male 20 (58.8 %) 30 (63.8 %)
Age 41.5 (7.9) 42.4 (8.8)
Ever injected drugs 23 (67.6 %) 38 (80.9 %)
Age of first injection 21.3 (3.4) 21.8(6.3)
Hepatitis C positive 20 (58.8 %) 29 (61.7 %)
Receiving methadone 33 (97.1 %) 47 (100 %)
Age first methadone use 25.6 (8.3) 25.8 (7.9)
Mean methadone dose 82.2 (22.7) 65.2 (28.6)
Attends Level 1 GP 15 (44.1 %) 26 (55.3 %)
Attends Level 2 GP 19 (55.9 %) 21 (44.7 %)
Geographical area of GP:
East 30 (88.2 %) 43 (91.5 %)
West 4 (11.8 %) 4 (8.5 %)
Employed 6 (17.6 %) 2 (4.3 %)
Current accommodation:
Rented 9 (26.5 %) 16 (34 %)
Owned 4 (11.8 %) 4 (8.5 %)
Family of origin 3 (8.8 %) 8 (17 %)
Social housing 15 (44.1 %) 17 (36.2 %)
Supported housing 2 (5.9 %) 2 (4.3 %)
No Fixed abode 1 (2.9 %) 0 (0 %)
Past 30-day drug use (self-reported)a
Number of patients who used illicit drugs in the last 30 daysb 14 (41.2 %) 17 (36.2 %)
Alcohol screening*
Q: Have you ever been asked about your alcohol use by healthcare professionals?
19 (55.9 %) 31 (66 %)
Alcohol brief intervention**
Q: Did they advise you on safe drinking or talk to you about alcohol?
14 (41.2 %) 23 (48.9 %)
Specialist referral***
Q: Have you ever been referred to a specialist/ addiction counsellor for alcohol use?
7 (20.6 %) 7 (14.9 %)
aData obtained from baseline patient questionnaires with data referring to the previous 30 days
bHeroin, illicit methadone, illicit benzodiazepines, cocaine, amphetamines, cannabis, other drugs
* ICC (SE) = 0.016 (0.014)
** ICC (SE) = –0.06 (0.017)
*** ICC (SE) = 0.22 (0.026)
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The decrease of drinking in the control group is con-
sistent with improvements that have been observed in
intervention trials targeting various health behaviours
and may occur in response to undergoing baseline as-
sessment, participants’ awareness of being involved in
experimental studies, or due to the delivery of a more
intensive ‘usual care’ than would be typically experienced
[37, 38]. Given the interaction with practices in the ‘con-
trol’ group, this is most likely what improved outcome
measures in this group.
This feasibility study was not designed to determine ef-
fectiveness and thus inferences on the likely efficacy of the
intervention should be interpreted with caution. Further-
more, it is likely that we recruited practices and patients
who were more positively disposed toward the intervention.
While it is evident that the final 15 GPs out of an original
pool of 149 represented a biased, self-selected sample, the
findings are still of value because we followed guidelines on
feasibility studies and we achieved our objectives, i.e. esti-
mating sample size for a future definitive trial, testing integ-
rity of study protocol, data collection instruments,
randomisation procedure, recruitment, consent, acceptabil-
ity of intervention and identification of most appropriate
primary outcome measure.
It appeared that the poor rate of GP participation was dir-
ectly connected to the complexity of the study protocol, the
intervention, the multiple data collection and measurement
instruments. The GP recruitment method and the pro-
posed intervention did not appear to be sufficiently attract-
ive in the eyes of the busy practitioners, despite the
financial incentive offered to them. The recognition of the
importance of the intervention was sufficient to attract par-
ticipating practitioners to the dedicated CME sessions;
nonetheless, for a definitive study, the research protocol
and instruments should be simplified and modified /
Table 5 SAAPPQ measuring general practitioners’ attitudes
towards the provision of care with those with alcohol use
disorders and GPs’ perceived barriers to alcohol screening at
baseline and follow up
Intervention (n = 6) Control (n = 7)
Mean (SD) Mean (SD)
Doctors' Attitudes Total SAAPPQa (SD)
Baseline 50.7 (6.7) 54.4 (7.6)
Follow up 54 (6.8) 56 (6.3)
Doctors' Attitudes SAAPPQ: Role Securityb (SD)
Baseline 23.2 (2.2) 21.9 (4.7)
Follow up 23.8 (3.8) 22.9 (1.2)
Doctors’ Attitudes SAAPPQ: Therapeutic Commitmentc (SD)
Baseline 27.5 (5.6) 32.6 (4.3)
Follow up 30.2 (4.5) 33.1 (3.9)
Barriers Total Meand (SD)
Baseline 15.2 (5.2) 16.2 (2)
Follow up 13.8 (1.6) 15.6 (1.6)
Lack of training in addiction
Baseline 3.2 (1.5) 4 (1.1)
Follow up 3.6 (1.3) 4.3 (0.8)
Lack of time
Baseline 2.8 (1.3) 2.3 (1.8)
Follow up 2.3 (1.8) 2.6 (0.5)
Lack of specialist staff
Baseline 2.8 (1.8) 3 (1.4)
Follow up 1.8 (0.8) 2.9 (1.5)
Poor service availability
Baseline 2.8 (1.7) 3.1 (1.1)
Follow up 2.3 (1.3) 2.7 (1.3)
Attitude of patient
Baseline 3.5 (1.4) 3.3 (1.5)
Follow up 3 (1.5) 3.1 (1.2)
aDoctors’Attitudes Total SAAPPQ - Short Alcohol and Alcohol Problems Perception
Questionnaire’ (SAAPPQ). This 10-item, 7-point Likert-type questionnaire measured
the attitudes of professionals towards the provision of care for patients with alcohol
use disorders. Total scores range from 10 to 70, with lower scores indicative of more
negative attitudes (refer to Additional file 1 for scoring code)
bDoctors' Attitudes SAAPPQ: Role Security - The role security domain within
the SAAPPQ includes 2 sub-domains: role adequacy, and role legitimacy
cDoctors’Attitudes SAAPPQ: Therapeutic Commitment - Therapeutic commitment
involves motivation, task specific self-esteem, and work satisfaction
dBarriers Total Mean - GPs rated the importance of each of five barriers to
alcohol screening, specifically: lack of training and education, lack of time, lack
of specialist staff, poor service availability and attitude of patients. They rated
their answers on a Likert scale from one to five (1 =most important and 5 =
least important; composite score 5–25)
Table 6 Process / Outcome measures at follow up (and
baseline where comparable) according to patient interviews
Process / outcome measure Intervention
(n = 34)
Control
(n = 47)
n (%) n (%)
Alcohol screening
Q: Have you been asked about your alcohol
use by healthcare professionals in the last
3 months?
18 (52.9 %) 12 (25.5 %)
Brief Intervention
Q: Did they advise you on safe drinking or
talk to you about alcohol in the last
3 months?
16 (47.1 %) 9 (19.2 %)
Specialist referral
Q: Have you been referred to a specialist/
addiction counsellor for alcohol use in the
last 3 months?
1 (2.9 %) 0 (0 %)
Abnormal AUDIT-C
At baseline 22 (66.7 %) 29 (61.7 %)
At follow upa 18 (54.5 %) 27 (57.5 %)
Abnormal AUDIT
At baseline 14 (41.2 %) 18 (38.3 %)
At follow up 8 (23.5 %) 10 (21.3 %)
aICC (SE) = 0.11 (0.013)
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minimised to increase acceptability to GPs and to improve
GP recruitment rate.
Conclusion
A complex intervention to support alcohol screening and
brief intervention among people receiving opioid agonist
treatment in primary care appears feasible. Future
research should address improving the complex interven-
tion to provide additional support to GPs in making
SBIRT a consistent part of their treatment for people re-
ceiving opioid agonist treatment. Strategies that maximise
and enhance recruitment (e.g. focussed engagement with
practices, targeting deprived regions, etc.) will be integral
to this study protocol. Enhanced contact and interaction
of researchers with GPs during the recruitment process
may encourage more active involvement of GPs.
Additional file
Additional file 1: Short Alcohol and Alcohol Problems Perception
Questionnaire. Questions designed to explore the attitudes of staff
working with people with alcohol use disorders. (DOC 47 kb)
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